KidsCancerKinome is an European project funded by the European Commission through the 6th Framework Programme for Research and Development. It aims at selecting and validating drug targets from the human kinome for high risk paediatric cancers.

KidsKancerKinome is a joined project of the 9 ITCC research laboratories and an SME focused on drug development (Santaris Pharmaceutics). The project began in November 1st 2006 and will last 3 years. It gathers 11 European partners.